Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mersana Therapeutics, Inc. - Common Stock
(NQ:
MRSN
)
29.08
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mersana Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Stocks That Hit 52-Week Lows On Thursday
↗
July 27, 2023
During Thursday, 56 stocks hit new 52-week lows.
Via
Benzinga
Nasdaq Up 1%; Meta Shares Surge Following Upbeat Results
↗
July 27, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Thursday. Following the market opening Thursday, the Dow traded up 0.15% to 35,573.49 while the NASDAQ...
Via
Benzinga
Why Mersana Therapeutics Stock Is Plunging Today?
↗
July 27, 2023
Mersana Therapeutics Inc (NASDAQ: MRSN) shares are sinking after the company announced that the UPLIFT clinical trial of upifitamab rilsodotin (UpRi) did
Via
Benzinga
What 4 Analyst Ratings Have To Say About Mersana Therapeutics
↗
June 16, 2023
Via
Benzinga
Mersana Therapeutics's Return On Capital Employed Insights
↗
May 24, 2023
Via
Benzinga
FDA Halts Mersana's Early-Stage Cancer Trial After Patient Death
↗
March 13, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
↗
July 27, 2023
Via
Benzinga
Dow Jumps 100 Points; US GDP Rises 2.4% In Q2
↗
July 27, 2023
U.S. stocks traded higher this morning, following the release of major economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.28% to 35,620.79 while the NASDAQ rose...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
July 27, 2023
Via
Benzinga
Cancer Drug Trials Put On Hold After Patients Died
↗
June 17, 2023
Recent reports from two drug companies that had been conducing separate clinical trials to evaluate cancer treatments reveal that the trials were halted due to the deaths of six participants, including...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
↗
June 16, 2023
Via
Benzinga
NVIDIA To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Friday
↗
June 16, 2023
Raymond James boosted the price target for Jabil Inc. (NYSE: JBL) from $100 to $120. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares rose 5% to close at $104.64 on...
Via
Benzinga
Crude Oil Rises Sharply; Jabil Posts Upbeat Q3 Results
↗
June 15, 2023
U.S. stocks traded higher toward the end of trading, with Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.32% to 34,429.39 while the NASDAQ rose 1.27% to 13,799.28. The S&P 500,...
Via
Benzinga
Mersana's UpRi Shows Potential in Ovarian Cancer; Analyst Initiates Coverage with Buy Rating
↗
June 15, 2023
Guggenheim Partners has initiated coverage on Mersana Therapeutics Inc (NASDAQ: MRSN) with a Buy rating
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
June 15, 2023
Via
Benzinga
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
June 15, 2023
Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.
Via
Benzinga
Dow Surges Over 300 Points; Kroger Profit Beats Views
↗
June 15, 2023
U.S. stocks traded higher midway through trading, with Dow Jones gaining more than 300 points on Thursday. The Dow traded up 0.98% to 34,313.85 while the NASDAQ rose 0.73% to 13,726.16. The S&P 500,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023
↗
June 15, 2023
Via
Benzinga
US Stocks Open Higher; Retail Sales Rise In May
↗
June 15, 2023
U.S. stocks traded higher this morning, with Dow Jones gaining around 180 points on Thursday. Following the market opening Thursday, the Dow traded up 0.53% to 34,159.59 while the NASDAQ rose 0.18% to...
Via
Benzinga
Coinbase Is Falling, but a Nasdaq Biotech Stock Is Thursday's Big Loser
↗
June 15, 2023
Markets gave back some ground after consideration of the Fed's latest interest rate decision.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
June 15, 2023
Via
Benzinga
Why Are Mersana Therapeutics Shares Nosediving Today
↗
June 15, 2023
The FDA has issued a partial clinical hold pausing new patient enrollment in Mersana Therapeutics Inc's (NASDAQ: MRSN) UP-NEXT and UPGRADE-A, the company's ongoing clinical trials of UpRi in
Via
Benzinga
7 Stocks to Buy for 200% Returns This Year
↗
June 13, 2023
These high return stock investments all have the potential to triple in 2023 based on Wall Street expectations.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 03, 2023
Via
Benzinga
US Stocks Edge Higher; AMD Shares Tank Despite Upbeat Results
↗
May 03, 2023
U.S. stocks traded up this morning, ahead of the Federal Reserve’s decision on an interest rate hike. Following the market opening Wednesday, the Dow traded up 0.05% to 33,700.93 while the NASDAQ rose...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
↗
March 16, 2023
Via
Benzinga
With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
↗
January 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
January 03, 2023
Via
Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
↗
December 23, 2022
Via
Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
↗
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
